Primary Record
GSK-A1
- In stock
- 2,216 g
- Purity
- 98.2 %
- CAS
- 1416334-69-4
Compound Identifiers & Properties
- CAS
- 1416334-69-4
- PubChem CID
- 71116366
- SMILES
- COC1=C(C=C(C=N1)C2=CC3=C(C=C2)N=C(N3C4=CC=C(C=C4)N5CCOCC5)N)S(=O)(=O)NC6=CC=CC=C6F
- Canonical SMILES
- COc1ncc(-c2ccc3nc(N)n(-c4ccc(N5CCOCC5)cc4)c3c2)cc1S(=O)(=O)Nc1ccccc1F
Names & Synonyms
- GSK-A1
- PI4KA inhibitor-A1
- 1416334-69-4
- PI4KA inhibitor-A1?
- A1;GSKA1
- C29H27FN6O4S
- orb1305074
- SCHEMBL14247403
- SCHEMBL29923006
- SCHEMBL30089076
- SYN1219
- MFCD29770784
- GLXC-07611
- BCP28055
- EX-A5297
- RGC33469
- AKOS037643421
- ZINC144874408
- AC-36732
- AS-16345
- SY491824
- HY-125118
- CS-0089366
- G62134
- A900427
- 5-[2-amino-3-(4-morpholin-4-ylphenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
- 5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
- 5-(2-Amino-1-(4-morpholinophenyl)-1H-benzimidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
- 5-(2-amino-1-(4-morpholinophenyl)-1H-benzo[d]imidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
- 5-[2-Amino-1-(4-morpholinophenyl)-1H-benzo[d]imidazol-6-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
- 5-[2-AMINO-1-[4-(MORPHOLIN-4-YL)PHENYL]-1H-1,3-BENZODIAZOL-6-YL]-N-(2-FLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFONAMIDE
- 5-[2-amino-3-(4-morpholinophenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxy-pyridine-3-sulfonamide
- 5-{2-AMINO-3-[4-(MORPHOLIN-4-YL)PHENYL]-1,3-BENZODIAZOL-5-YL}-N-(2-FLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFONAMIDE
- E4S
- GSK-A1|1416334-69-4|5-[2-amino-3-(4-morpholin-4-ylphenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|PI4KA inhibitor-A1|A1